Christopher Franklin Devall A Ikido Pharma Inc. (AIKI) insider trading activity
Christopher Franklin Devall is COO of AIkido Pharma Inc.. Currently has a direct ownership of 155,702 shares of AIKI, which is worth approximately $591,667. The most recent transaction as insider was on Dec 11, 2025, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
156K
62.09%
3M change
418.44%
12M change
Total Value Held
$591,667
Christopher Franklin Devall Transaction History
CFD
Christopher Franklin Devall
COO
New York, NY